Lets take a look at the research and implications of people who have taken GLP-1 agonists along with various gastrointestinal conditions
Effects of Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide on Cardiovascular and Renal Outcomes Across Body Mass Index Categories in Type 2 Diabetes: Results of the LEADER and SUSTAIN 6 Trials
Guidelines for Alcohol Consumption While Using Ozempic While occasional moderate alcohol consumption may not be entirely off-limits for everyone on Ozempic, prioritizing safety and understanding the potential risks are crucial
Although their own exclusion criteria is more inclusive than the phase III clinical trials, they still exclude populations diagnosed with: depression, bipolar depression, schizoaffective disorder, anxiety and suicidal ideation within a year prior and a week a er the start of drug therapy
Supporting metabolic functions: When metabolism slows, weight gain follows
GLP BodyGuard Consumer Research: Muscle Loss Tracking for GLP-1 Users TL;DR - GLP BodyGuard Quick Answer (2026) In 2026, most GLP-1 users track their weight
